Ahmed Adam1,2,3,4, Julian C Hellig5,6,7, Marlon Perera8,9, Damien Bolton8,10, Nathan Lawrentschuk8,10,11. 1. Department of Urology, Helen Joseph Hospital, Johannesburg, South Africa. aadam81@gmail.com. 2. Department of Paediatric Urology, Rahima Moosa Mother and Child (Coronation) Hospital, Johannesburg, South Africa. aadam81@gmail.com. 3. The Division of Urology, Department of Surgery, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa. aadam81@gmail.com. 4. Division of Urology, Department of Surgery, Wits Medical School, 9th Floor, Room 9S19, 07 York Road, Parktown, Private Bag X3, Johannesburg, 2050, South Africa. aadam81@gmail.com. 5. Department of Urology, Helen Joseph Hospital, Johannesburg, South Africa. 6. Department of Paediatric Urology, Rahima Moosa Mother and Child (Coronation) Hospital, Johannesburg, South Africa. 7. The Division of Urology, Department of Surgery, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa. 8. Department of Surgery, Austin Health, University of Melbourne, Melbourne, VIC, Australia. 9. Department of Surgery, University of Queensland, Brisbane, QLD, Australia. 10. Olivia-Newton John Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. 11. Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Abstract
PURPOSE: The use of mobile phone applications (Apps) has modernised the conventional practice of medicine. The diagnostic ability of the current Apps in prostate specific antigen monitoring, and its diagnostic ability within prostate cancer (PCa) risk calculators have not yet been appraised. We aimed to review, rate and assess the everyday functionality, and utility of all the currently available PCa risk calculator Apps. METHODS: A systematic search on iTunes, Google Play Store, Blackberry World and Windows Apps Store, was performed on 23/11/2017, using the search term 'prostate cancer risk calculator'. After applying the exclusion criteria, each App was individually assessed and rated using pre-set criteria and grading was performed using the validated uMARS scale. RESULTS: In total, 83 Apps were retrieved. After applying our exclusion criteria, only 9 Apps were relevant, with 2 duplicated, and the remaining 7 were suitable for critical review. Data sizes ranged from 414 kb to 10.1 Mb. The cost of the Apps ranged from South African rand (ZAR) 0.00 to ZAR 29.99. The overall mean category uMARS scores ranged from 2.8/5 to 4.5/5. Apps such as Rotterdam Prostate Cancer Risk Calculator, Coral-Prostate Cancer Nomogram Calculator and CPC Risk Calculator, performed the best. CONCLUSIONS: The current PCa risk calculator mobile Apps available may be beneficial in counselling the concerned at risk patient. These Apps have potential to assist both the patient and the urologist alike. The PCa risk calculator App 'predictability' may be further enhanced by the incorporation of newly validated risk factors and predictors for PCa.
PURPOSE: The use of mobile phone applications (Apps) has modernised the conventional practice of medicine. The diagnostic ability of the current Apps in prostate specific antigen monitoring, and its diagnostic ability within prostate cancer (PCa) risk calculators have not yet been appraised. We aimed to review, rate and assess the everyday functionality, and utility of all the currently available PCa risk calculator Apps. METHODS: A systematic search on iTunes, Google Play Store, Blackberry World and Windows Apps Store, was performed on 23/11/2017, using the search term 'prostate cancer risk calculator'. After applying the exclusion criteria, each App was individually assessed and rated using pre-set criteria and grading was performed using the validated uMARS scale. RESULTS: In total, 83 Apps were retrieved. After applying our exclusion criteria, only 9 Apps were relevant, with 2 duplicated, and the remaining 7 were suitable for critical review. Data sizes ranged from 414 kb to 10.1 Mb. The cost of the Apps ranged from South African rand (ZAR) 0.00 to ZAR 29.99. The overall mean category uMARS scores ranged from 2.8/5 to 4.5/5. Apps such as Rotterdam Prostate Cancer Risk Calculator, Coral-Prostate Cancer Nomogram Calculator and CPC Risk Calculator, performed the best. CONCLUSIONS: The current PCa risk calculator mobile Apps available may be beneficial in counselling the concerned at risk patient. These Apps have potential to assist both the patient and the urologist alike. The PCa risk calculator App 'predictability' may be further enhanced by the incorporation of newly validated risk factors and predictors for PCa.
Authors: Prahara Yuri; Grace Wangge; Fatan Abshari; Adistra I T W H Satjakoesoemah; Noor R Perdana; Candra D K Wijaya; Christiano Tansol; Aaron Tigor; Ferry Safriadi; Dhiraya D Kadar; Syah M Warli; Sungsang Rochadi; Lukman Hakim; Wahjoe Djatisoesanto; Sunaryo Hardjowijoto; Chaidir A Mochtar; Rainy Umbas; Agus Rizal A H Hamid Journal: Acta Med Indones Date: 2015-04
Authors: Robert W Foley; Robert M Maweni; Laura Gorman; Keefe Murphy; Dara J Lundon; Garrett Durkan; Richard Power; Frank O'Brien; Kieran J O'Malley; David J Galvin; T Brendan Murphy; R William Watson Journal: BJU Int Date: 2016-02-29 Impact factor: 5.588
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Sam F Peisch; Erin L Van Blarigan; June M Chan; Meir J Stampfer; Stacey A Kenfield Journal: World J Urol Date: 2016-08-12 Impact factor: 4.226
Authors: Jacqueline Lorene Bender; Rossini Ying Kwan Yue; Matthew Jason To; Laetitia Deacken; Alejandro R Jadad Journal: J Med Internet Res Date: 2013-12-23 Impact factor: 5.428
Authors: Shlomi Tapiero; Renai Yoon; Francis Jefferson; John Sung; Luke Limfueco; Courtney Cottone; Sherry Lu; Roshan M Patel; Jaime Landman; Ralph V Clayman Journal: World J Urol Date: 2019-10-09 Impact factor: 4.226
Authors: Anne L Potzel; Christina Gar; Friederike Banning; Vanessa Sacco; Andreas Fritsche; Louise Fritsche; Karsten Müssig; Laura Dauben; Jochen Seissler; Andreas Lechner Journal: PLoS One Date: 2022-04-27 Impact factor: 3.752
Authors: Guglielmo Mantica; Rafaela Malinaric; Federico Dotta; Irene Paraboschi; Giovanni Guano; Silvia Rebuffo; Massimo Garriboli; Nazareno Suardi; André Van der Merwe; Carlo Terrone Journal: Cent European J Urol Date: 2020-08-07
Authors: I Grootes; J K Barrett; P Ulug; F Rohlffs; S J Laukontaus; R Tulamo; M Venermo; R M Greenhalgh; M J Sweeting Journal: Br J Surg Date: 2018-09 Impact factor: 6.939